Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis

Rheumatology

Volumn 48, Issue 3, 2009, Pages 318-319

  Kawai, M ^a   Hagihara, K ^a   Hirano, T ^a   Shima, Y ^a   Kuwahara, Y ^a   Arimitsu, J ^a   Narazaki, M ^a   Ogata, A ^a   Kawase, I ^a   Kishimoto, T ^b   Tanaka, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATLIZUMAB; AUTOANTIBODY; C REACTIVE PROTEIN; COLLAGEN TYPE 2; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTHRALGIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; DYSPNEA; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; RELAPSING POLYCHONDRITIS; RESPIRATORY TRACT DISEASE; SCLERITIS; THORAX PAIN; TRACHEOTOMY; VISUAL ANALOG SCALE; WHEEZING;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; RECEPTORS, INTERLEUKIN-6;

EID: 61349092994     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken468     Document Type: Letter

References (9)

1. Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol 2006;24:482-5.
2. Saadoun D, Deslandre CJ, Allanore Y, Charlier C, Pham X-V, Kahan A. Sustained responses to infliximab in 2 patients with refractory relapsing polychondritis. J Rheumatol 2003;30:1394-5.
3. Mpofu S, Estrach C, Curtis J, Moots RJ. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology 2003;42:1117-8.
4. Kraus VB, Stabler T, Le ET, Saltarelli M, Allen NB. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis. Arthritis Rheum 2003;48:2942-8.
5. Carter JD. Treatment of relapsing polychondritis with a tumor necrosis factor antagonist. J Rheumatol 2005;32:1413.
6. Vounotrypidis P, Sakellariou GT, Zisopoulos D, Berberidis C. Refractory relapsing polychondritis: Rapid and sustained response in the treatment with IL-1 receptor antagonist (anakinra). Rheumatology 2006;45:491-2.
7. Seymour MW, Home DM, Williams RO, Allard SA. Prolonged response to anti-tumor necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. Rheumatology 2007;46:1738-9.
8. Nishimoto N, Kishimoto T. Humanized anti-human IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 2008;181:151-60.
9. Stabler T, Piette J-C, Chevalier X, Marini-Portugal A, Kraus VB. Serum cytokine profiles in relapsing polychondritis suggest monocyte/ macrophage activation. Arthritis Rheum 2004;50:3663-7.